Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

134 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Upadacitinib induction is effective and safe in ulcerative colitis patients including those with prior exposure to tofacitinib: a multicenter real-world cohort study.
Gilmore R, Fernandes R, Hartley I, Arzivian A, Leong R, Andrew B, Vasudevan A, Greeve T, Moore GT, Kim S, Lightowler D, Singh A, Mahy G, Mithanthaya A, Venugopaul K, Han S, Bryant R, West J, Segal J, Christensen B, Corte C, Ding N, An YK, Begun J. Gilmore R, et al. Among authors: moore gt. Intest Res. 2024 Dec 20. doi: 10.5217/ir.2024.00127. Online ahead of print. Intest Res. 2024. PMID: 39709985 Free article.
6-Thioguanine nucleotide levels are associated with infliximab but not adalimumab levels in inflammatory bowel disease patients on combination therapy.
Yu N, Lee T, Tassone D, Vogrin S, Phan S, Wu DM, Zhang J, Wang L, Tjahyadi J, Dutt K, Liou H, Basnayake C, Wright E, Niewiadomski O, Lust M, Schulberg J, Kamm MA, Connell W, Thompson AJ, Hilmi I, Raja Ali RA, Wei SC, De Cruz P, Friedman AB, Moore GT, Van Langenberg D, Ding NS. Yu N, et al. Among authors: moore gt. Intern Med J. 2024 Nov;54(11):1856-1866. doi: 10.1111/imj.16504. Epub 2024 Sep 5. Intern Med J. 2024. PMID: 39234975
Switching from Dose-Intensified intravenous to SubCutaneoUS infliximab in Inflammatory Bowel Disease (DISCUS-IBD): protocol for a multicentre randomised controlled trial.
Little RD, McKenzie J, Srinivasan A, Hilley P, Gilmore RB, Chee D, Sandhu M, Saitta D, Chow E, Thin L, Walker GJ, Moore GT, Lynch K, Andrews J, An YK, Bryant RV, Connor SJ, Garg M, Wright EK, Hold G, Segal JP, Boussioutas A, De Cruz P, Ward MG, Sparrow MP. Little RD, et al. Among authors: moore gt. BMJ Open. 2024 Jul 20;14(7):e081787. doi: 10.1136/bmjopen-2023-081787. BMJ Open. 2024. PMID: 39032928 Free PMC article.
Local fistula injection of allogeneic human amnion epithelial cells is safe and well tolerated in patients with refractory complex perianal Crohn's disease: a phase I open label study with long-term follow up.
Keung C, Nguyen TC, Lim R, Gerstenmaier A, Sievert W, Moore GT. Keung C, et al. Among authors: moore gt. EBioMedicine. 2023 Dec;98:104879. doi: 10.1016/j.ebiom.2023.104879. Epub 2023 Dec 1. EBioMedicine. 2023. PMID: 38042747 Free PMC article. Clinical Trial.
134 results